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China in Global Landscape of Life Sciences
Abstract
The development of life science for over 150 years can be summarized into three stages:classical
genetics, molecular genetics and molecular biology, life omics and systems biology. The contemporary
life science is unprecedentedly prosperous, showing several new characteristics:original discoveries
emerge in endlessly, promoting massive bottom-level innovations; the convergence of multiple disciplines
promotes biological sciences from qualitative description to dynamic, precise and quantitative
interpretation; scientific data sharing has become a common rule in the life science community; and the
rise of synthetic biology and artificial intelligence (AI) provides a new paradigm for life science research.
These characteristics enable the knowledge about life to be greatly enriched and biotechnology to be
rapidly iteratively upgraded. At the same period, China's life sciences have made remarkable progress
after decades of accumulation, gradually changing the global landscape of life sciences, which has been
well demonstrated by the outstanding contribution of Chinese scientists in the fight against the COVID-19.
With the profound changes in the political and economic landscape of the world in recent years, China's
life sciences face more challenges. Rationalizing the functional positioning and resource allocation of
various R&D sectors, and creating a healthy research culture and atmosphere will enable China's life
sciences to further consolidate its foundation and become more exceptional, play a pillar role in
construction of an innovation country, and give rich returns to human society and economy.
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Abstract: The development of life science for over 150 years can be summarized into three stages: classical genetics, molecular genetics and molecular biology, life omics and systems biology. The contemporary life science is
unprecedentedly prosperous, showing several new characteristics: original discoveries emerge endlessly, promoting
massive bottom-level innovations; the convergence of multiple disciplines promotes biological sciences from qualitative description to dynamic, precise and quantitative interpretation; scientific data sharing has become a common
rule in the life science community; and the rise of synthetic biology and artificial intelligence (AI) provides a new
paradigm for life science research. These characteristics enable the knowledge about life to be greatly enriched and
biotechnology to be rapidly iteratively upgraded. In the same period, China’s life sciences have made remarkable
progress after decades of accumulation, gradually changing the global landscape of life sciences, which has been
well demonstrated by the outstanding contribution of Chinese scientists in the fight against the COVID-19. With the
profound changes in the political and economic landscape of the world in recent years, China’s life sciences face
more challenges. Rationalizing the functional positioning and resource allocation of various R&D sectors, and creating a healthy research culture and atmosphere will enable China’s life sciences to further consolidate its foundation and become more exceptional, play a pillar role in construction of an innovation country, and give rich returns
to human society and economy. DOI: 10.16418/j.issn.1000-3045.20220426003-en
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Life sciences, the natural sciences that study the essence
and rules of life, are associated with human health. This paper
outlines the development of life sciences from the macroscopic perspective, summarizes the characteristics and hot
topics of contemporary life sciences, and analyzes the position of China in the global landscape of life sciences. Furthermore, this paper introduces China’s representative
achievements in life science research in the past 10 years and
puts forward the questions requiring attention and solutions
in the future.

1 Development of life sciences in the last
century: three 50-year stages
Landmark events occur about once every half century
(Figure 1), and thus the nearly 150-year history of life sciences can be summarized into three stages. In the middle 19th
century, Gregor Johann Mendel discovered the basic laws of
genetics by pea planting experiments and proposed the laws
of Mendelian inheritance (1865). Later, Thomas Hunt Morgan located genetic factors on chromosomes following
studies on fruit flies (1910). They jointly laid the foundation
for the first stage: classical genetics. In the middle 20th
century, James Watson and Francis Crick discovered the

double helix structure of DNA (1953), which marked the
second stage: molecular genetics and molecular biology.
During this stage, the genetic code of life and the central
dogma of DNA-RNA-protein were discovered, which gave
rise to genetic biotechnology to benefit mankind. With the
implementation and completion of Human Genome Project
in the late 20th century and early 21st century, life sciences
entered the third stage: life omics and systems biology. At
this stage, many complex life processes and disease mechanisms have been clarified. Genome sequencing, synthesis,
and editing, as well as the integration of life sciences with
artificial intelligence, are writing a new chapter of reading-modifying-writing genomes. Scientists are beginning to
write synthetic life forms and accurately regulate life
processes.
The three stages are also interlinked three rounds of life
science revolution, which mark the profound changes in life
science research paradigm, from observations on phenotypes
and inheritance to molecular biological characterization of
life processes, and further to application of omics in systems
biology. These changes have affected various fields of life
science research and promoted comprehensive progress in
medical sciences, agricultural biology and other fields,
greatly contributing to human health and economic and social
development.
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Figure 1

Landmark events and three 50-year stages in life sciences

2
Characteristics of contemporary life
sciences
Driven by the new round of scientific and technological
revolution, life sciences present the following five
characteristics.
(1) Original discoveries emerge endlessly, promoting
massive bottom-level innovations. Molecular and cellular
biology has penetrated into the whole disciplinary system and
become the pillar of basic and applied disciplines of life
sciences, promoting endless original discoveries and bottomlevel innovations. For example, powerful gene-editing techniques [1,2] originate from the discovery of CRISPR, the molecular mechanism by which microorganisms and archaea
have evolved adaptive immunity to virus (phage) infection [3,4].
The polymerase chain reaction (PCR) that transforms molecular biology is born from the discovery of heat-tolerant
DNA polymerases in extremophiles [5]. The discovery of
immune checkpoints (CTLA-4 and PD-1) [6,7] and cellular
immunology have fostered an upsurge in targeted immunotherapy for tumors [8–10], which is overturning the traditional
cancer treatment model. The deciphering of RNA interference (RNAi) mechanism [11] has inspired the application of
gene silencing in the treatment of genetic diseases. Moreover,
the discoveries of apoptosis [12], pyroptosis [13], necroptosis [14],
autophagy [15], ferroptosis [16], and phase transition [17] help
reveal the ingenious self-regulatory mechanisms of cells in
physiological and pathological processes, which have given
birth to new treatment strategies for major diseases.
(2) Equal emphasis is put on systems theory and reductionism to unravel complex life processes. In the field of
molecular biology, a variety of functional genes have been
annotated, on the basis of which the life processes and disease
pathogenesis have been linked with the functional genes as
well as transcription and expression products. If this is called
reductionism, the life omics composed of genomics, transcriptomics, proteomics, and metabolomics is a systemic
understanding of the complex life network. The combination
of “bottom-up” and “top-down” research has provided the
opportunities for discoveries in life sciences and spawned
new research directions and frontier hot spots. For example,

the integration of genomics with molecular biology and
clinical data of disease connects precision medicine with
personalized treatments [18–20]. Human microbiome and
metabolome are associated with health and diseases [21,22],
while intestinal microbiome and metabolome provide a new
perspective to explain the principles of traditional Chinese
①
medicine . The genomic and transcriptomic studies as well
as functional annotations of genes have revealed that only 2%
of the genome encodes proteins, while the remaining 98%
with unknown function is likened to the dark matter of the
genome [23]. Many non-coding RNAs play a key role in the
spatio-temporal regulation of networks in cells [24], which
opens up a new field for biology and has unlimited potential
in future follow-up studies [25].
(3) The convergence of multiple disciplines promotes biological sciences from qualitative description to dynamic,
precise, and quantitative interpretation. Genetic variations of
life systems, spatio-temporal dynamics of metabolism and
regulation, and flexibility of life substances jointly determine
the complexity of life processes. The current knowledge
accumulated in life sciences is the integration of qualitative
fragmented results. The establishment and application of
physical and chemical methods and technological platforms,
such as super-resolution microscopic imaging, cryo-electron
microscopy, mass cytometry, mass spectrometric imaging,
magnetic resonance imaging, enhanced Raman spectroscopy,
patch clamp, optical tweezers, nanopore sequencing,
nano-biosensing, miniaturized total analysis system (µTAS),
organ-on-a-chip, and three-dimensional bioprinting, have
provided powerful tools for life science research to enable
single-cell, visual, high-throughput, high-temporal resolution
analysis and manipulation. Up to now, high-resolution brain
atlas [26,27], single-cell transcriptome [28,29], single-cell proteome [30], embryonic cell lineage [31], determination of protein three-dimensional structure in living eukaryotic cells [32],
tracing of single-particle virus in living cells [33,34], and multitissue interactions in an chip[35,36], and organoid engineering [36] have been achieved. Life systems are accurately,
quantitatively, visually characterized and even successfully
simulated at the microscopic level.
(4) Scientific data sharing has become a common rule in
the life science community. The life science databases
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represented by gene database and protein structure database
play a key role in modern life science research. The database
builders and the scientific community have reached a consensus that researchers are both users and contributors to the
databases as they use the databases and deposit their data
(gene sequences or protein structures) in the databases.
Nowadays, databases have become the most reliable record
carriers and powerful data analysis platforms of life history
book, which is relied on by the whole life science community.
For example, since the COVID-19 pandemic, there have been
over 10 million SARS-CoV-2 genome sequences regis②
tered
The data are published in real-time by the Global
Initiative on Sharing All Influenza Data (GISAID), China
National Center for Bioinformation (CNCB), National Center for Biotechnology Information (NCBI), and European
Bioinformatics Institute (EBI). The data have provided a
basis for the etiological and molecular epidemiological
studies of COVID-19, as well as the establishment of detection technology and R&D of drugs and vaccines against
SARS-CoV-2, thereby playing an important role in the global
responses to COVID-19.
(5) The rise of synthetic biology and artificial intelligence
(AI) provides a new paradigm for life science research. ①
Synthetic biology emerges in the 21st century [37,38]. It combines life sciences, physics, chemistry, materials science,
computer and information science to redesign and synthesize
organisms by integrating engineering concepts with automation technologies [39]. It employs the “bottom-up” model to
build expected artificial life systems and study the underlying
rules of life, from the characterization of natural macromolecules into standardized elements, to the creation of biological elements and cell chassis, such as modules and circuits.
This principle pushes the accustomed research strategy of
“obtaining knowledge by studying” to a new height of “obtaining knowledge by building things” [40]. However, given
the complexity of biological systems, the rational design of
biological systems currently relies on high-throughput
trial-and-error experiments, which leads to the emergence of
biofoundary, i.e., the facility of biological design and synthesis automation. That is why another idea of synthetic biology, “making things for application”, is spurring the future
of biotechnology. ② The most typical example of the application of AI in life sciences, is the prediction of protein
three-dimensional structure based on big data, algorithms,
and machine learning. For a long time, the progress in protein
structure prediction is very slow. If the structure of the homologous protein is unavailable for a protein with unknown
structure, we need to determine its structural information
through experiments. Google’s DeepMind team shared the
open source code of AlphaFold in Nature in 2021 after AlphaFold won first place in the biannual Critical Assessment

of protein Structure Prediction (CASP) [41]. At the same time,
RoseTTAFold, a new deep learning tool, was unveiled in
Science by a team at the University of Washington [42]. Later,
AlphaFold2 predicted the three-dimensional structure of
98.5% of human proteins with high accuracy [43]. The
DeepMind team has published the AlphaFold database,
which provides unprecedented coverage for spatial structures
of the known protein sequences. The initial version of the
database contains more than 360 000 predicted structures in
21 proteomes of model species and will soon be expanded to
cover most (more than 100 million) representative sequences
from the UniRef90 dataset (validated protein sequences) [44].
These advances are groundbreaking for structural biology,
which is manifested in two aspects. ① The data of protein
three-dimensional structure will increase exponentially and
provide a better data basis for machine learning, thereby
enabling the quality defects that still exist in AI prediction for
protein structure to be successively solved. ② As the structures and functions of proteins are fundamental topics in
molecular and cellular biology, such advances will profoundly impact life sciences.

3 Contribution of high impact research in life
sciences in China
3.1 Publishing of high impact papers in the past
decade
The visualization of research paper publishing based on
the data of scientific literature database can macroscopically
reveal the contribution and development level of a country’s
scientific research. For a rapidly developing country, it is
obviously biased to use the total number of papers and the
number of citations per paper for evaluation of the research
progress, while the total number of citations is relatively
reasonable [45]. However, China has more than 5 million
full-time R&D personnel per year, far more than those in
③
Europe and the United States , which means the study of
high impact papers is of greater significance. This study
utilizes the scientific research evaluation and analysis platform InCite of Clarivate Analytics to analyze only the top 1%
papers with high citations in the same field (hereinafter referred to as the “top 1% papers”). Although there may be a
few exceptions (i.e., not really high academic impact) and
scientific papers do not represent the whole scientific and
technological strength, the top 1% papers generally reflect
outstanding studies of high academic impact. Figure 2 illustrates the top 15 countries (hereinafter referred to as the “top
15 countries”) in publishing of the top 1% of life science
papers, showing the distribution and rank of high impact
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research output of countries with strong science and technology in the past 20 years. After 20 years of following,
China, with a poor foundation of life science research, got
into the top 15 countries in the first decade of the 21st century
and has shown a sustained and strong momentum of growth
since then. In 2012, 2016, and 2021, the top 1% papers in
biological sciences published by Chinese researchers accounted for 5.5%, 8.1%, and 14.1%, respectively; those in
medical sciences accounted for 3.1%, 5.2%, and 8.0%, respectively; and those in agricultural sciences accounted for
9.4%, 15.2%, and 24.8%, respectively (Figure 3). The analysis in this study was mainly based on the above three major
fields and neglected some secondary disciplines overlapped
in the three major fields, which did not affect the trends as
demonstrated by the results. In addition, the contributions of
researchers from Hong Kong, Macao, and Taiwan of China
were not counted.
The significant increase in China’s high-impact research
papers in life sciences represents a substantial improvement
in the overall research level, which can be attributed to the
following four reasons. ① Emphasis on science and technology. A double-digit growth in R&D investment for nearly
20 years ensured the funds for life science research. ②
Growing research teams. China has ranked first in the number
of R&D personnel (including those who have returned to
China after studying and those who have grown up locally)
worldwide since 2013, which laid the foundation of a talent
highland. ③ Funding for a variety of research programs in
frontier fields. The funding for research programs significantly improves research conditions and experimental platforms. Meanwhile, the funding from the National Natural
Science Foundation keeps increasing. ④ Extensive international

Figure 2

cooperation. In the past 20 years, the papers published jointly
by Chinese researchers and overseas researchers accounted
for more than 23%, among which high impact papers accounted for 2.9%, twice the proportion of high impact papers
in all papers published by Chinese researchers. The condition
is similar to the research in life sciences.

3.2
Examples of China’s significant research
achievements in life sciences in the past 10 years
The highly cited papers are retrospective and time-tested,
while the annual scientific advances selected by the scientific
community are hot spots. There are two annual awards related to the progress in life sciences in China. ① The Top 10
Scientific Advances in China was established by the
High-Tech Research and Development Center (Administrative Center for Basic Research) of the Ministry of Science
and Technology of China in the early 21st century. The
winners are voted by the academicians of the Chinese
Academy of Sciences and the Chinese Academy of Engineering, directors of the State Key Laboratories, and chief
scientists of the National Key Basic Research Program of
China. ② The annual Top 10 Advances in Life Sciences in
China was founded in 2015. The winners are selected by the
Life Science Society of the China Association for Science
and Technology. The results of the two awards often highly
coincide. The former award has gone through 20 years, and I
was often invited to wholly comment on the results of the
selection and was deeply impressed. Here, the awarded
studies in the past 10 years are sorted out. Most of these
studies aim to solve targeted problems, or have an important
impact on science, or demonstrate significant application
value in medicine and food security.

Changes in global landscape of life sciences show that China has made remarkable progress over the past 10 years

Area of each square in figures represents the number of high impact (top 1% highly cited) papers produced by country and its ranking in world’s top 15
countries. Drawn from Clarivate Analytics’s InCite/Web of Science data
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Figure 3 Ten years’ changes of the proportion of high impact papers in life sciences published by top 15 countries in total number of high
impact papers in life sciences
For top 1% high impact papers in life sciences, the calculated is output proportion of top 5 countries in total output of top 15 countries and changes over the
past 10 years. Data collection is from 2012, 2016, and 2021. See Figure 2 for top 15 countries in life sciences. Drawn from Clarivate Analytics’s InCite/Web
of Science data

(1) Molecular genetics and cell biology. Sperm RNA
could be used as a memory carrier to transfer acquired traits
across generations [46]. A fine licensing and activation of early
replication origins was unraveled [47]. The role of Tet dioxygenases in epigenetic regulation in mammalian cells was
reported [48–50]. The molecular mechanisms of gene expression and epigenetic regulation in human primitive germ cells
were dissected [51]. Moreover, the molecular mechanism of
nutrient deficiency in triggering autophagy was deciphered [52,53]. Epigenetics achievements were continuously
selected, reflecting the development trend of molecular genetics, and Chinese researchers contributed 15.5% of the
highly cited papers worldwide (2011–2021).
(2) Structural biology. The structures and roles of the
proteins involved in underwater photosynthesis of algae [54],
structure and assembly mechanism of African swine fever
virus [55], key molecular mechanisms of RNA splicing [56,57],
structure of human glucose transporter [58], three-dimensional
structure of pathogenic protein for Alzheimer’s disease [59],
and structural basis [60] for specific recognition of DNA by
TAL effectors were reported. The structural dissection of
these important protein complexes is of great significance to
the understanding of their molecular machinery. Since the
emergence of cryo-electron microscopy, Chinese researchers
have dissected the three-dimensional structures of many
important proteins, including a batch of key proteins of
SARS-CoV-2. As mentioned earlier, AI for predicting the
three-dimensional structure of proteins is becoming increasingly powerful. Structural biologists are thinking about how
to ride the wave and deepen the research on protein structure
④
and function .

(3) Stem cells, regenerative medicine, and reproduction
and development. After Chinese scientists firstly cloned mice
with iPS cells [61,62], they gradually formed a strong lineup in
the field of cell biology and animal cloning. The representative results are summarized as follows: in-depth study of
markers and intervention targets for multi-organ aging [63],
confirmation of the ability of haploid solitary male stem cells
to replace sperm and rapidly deliver gene modifications [64,65],
and cloning of macaque monkeys by somatic cell nuclear
transfer [66]. In the past 5 years, the contribution rate of Chinese researchers to highly cited papers was 20.3%. “Organ
Reconstruction and Manufacturing”, a Strategic Priority
Research Program of Chinese Academy of Sciences, has
systematically deployed organ regeneration in situ, in vitro
manufacturing and allogeneic regeneration, aiming to address the fundamental problem that complex organs of higher
mammals are difficult to regenerate. Currently, this program
has made a few important original discoveries and technological innovations, some of which have entered clinical
studies.
(4) Mechanism, diagnosis, and treatment of major diseases. The representative achievements are summarized as
follows: the proposal of a treatment scheme for autoimmune
diseases based on DNA detection enzyme regulation [67], the
construction of the first non-human primate autism model [68],
the report of depression occurrence and rapid anti-depression
effect of ketamine [69], and the establishment of a new method
for tumor immunotherapy based on the modulation of cholesterol metabolism [70]. The treatment of leukemia by
targeting specific proteins with two natural products [71,72] is a

______________________________________
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systematic contribution of Chinese scientists who cured acute
promyelocytic leukemia for the first time. Chinese researchers have for the first time revealed the key molecular mechanism of pyroptosis, providing a new drug target for a variety
of autoinflammatory diseases, redefining the concept of pyroptosis and initiating a new research field of programmed
cell death [13].
(5) Etiological biology and infectious diseases. Chinese
researchers have made systematic contributions to the responses to COVID-19, with significant achievements in
etiological biology [73,74], structural biology [75–77], molecular
epidemiology [78], immunology [79], detection technology [80],
drugs [81], vaccine development and application [82], and
clinical diagnosis and treatment [83]. They have published
more than 1 450 highly cited papers and more than 200 hot
papers, which accounted for 20% of the total number
worldwide. Among these advances, “Cryo-EM structure of
an extended SARS-CoV-2 replication and transcription
complex reveals an intermediate state in cap synthesis” [75]
was selected as one of the Top 10 Scientific Advances of
2021. Other important achievements include the evolution
and genetic diversity of Ebola virus [84], breakthroughs in
tracing the origin of Avian influenza A (H7N9) virus and the
interspecies transmission mechanism of Avian influenza A
(H5N1) [85]. Moreover, the discovery of hepatitis B virus
(HBV) receptor sodium taurocholate co-transporting polypeptide (NTCP) laid a foundation for addressing HBV infection of cells and developing anti-HBV drugs [86]. By
revealing the structure and assembly mechanism of African
swine fever virus [55], scientists provided a solution to the
development of African swine fever virus vaccine based on
structural biology.
(6) Agricultural biology. Some representative achievements are summarized as follows: modulating
growth-metabolism coordination of plants for sustainable
agriculture [87], genomic architecture of heterosis for yield
traits in rice [88], dissection of the secret that 4-vinylanisole is
an aggregation pheromone in locusts [89], and ecological
experiments to confirm that widespread adoption of Bt cotton
promotes biocontrol services [90]. Notably, after the Green
Revolution represented by genes for semi-dwarf trait, Chinese scientists represented by Yuan Longping achieved a
breakthrough in hybrid breeding theory and technology of
rice, which is the second leap forward. Later, Yuan Longping
devoted his whole life to the breeding of super rice, with the
yield per mu (1 mu = 666.7 m2) exceeding 1 000 kg for the
first time (Top 10 Science and Technology Advances of
2014). Further, the “molecular mechanism of high-yield and
high-quality traits in rice and variety design” of Li Jiayang’s
team won the first prize of the National Prize for Natural

Sciences in 2017, which was praised as the third breakthrough after the Green Revolution and hybrid rice by Li
Zhensheng, the father of hybrid wheat, marking the starting
⑤
point of the New Green Revolution . The contribution of
Chinese researchers has provided an important technological
path for global food security and is a major contribution to
mankind.
(7) Synthetic biology. Accurate synthesis of yeast chromosomes [91–93] and the creation of a functional singlechromosome yeast [94] have opened a new research field for
chromosome engineering. It is safe and effective to transform
the virus directly into live vaccine by expanding the codon [95]. Moreover, intelligent DNA nanorobots were designed for tumor therapy [96]. In the past 5 years, Chinese
researchers contributed more than 20% to both highly cited
papers and hot papers. After the creation of a cell-free synthetic pathway from carbon dioxide to starch in 2021 [97],
Chinese researchers successively reported a minimized synthetic carbon fixation cycle [98] and the synthesis of glucose
and fatty acids from carbon dioxide reduction in 2022 [99].
These pioneering studies seek to recycle carbon dioxide,
provide multiple paths for industrial biomanufacturing and
potentially serve the “dual carbon” goals.
(8) Biogenesis and evolution. Chinese researchers have
made a series of remarkable achievements regarding
Chengjiang fossils, known as one of the most amazing scientific discoveries of the 20th century. Recently, Chinese
researchers have revealed the evolution and migration history
of the Chinese population in recent ten thousand years by a
paleogenomic study [100], and depicted the evolution history
of the earth’s biodiversity in 300 million years with the
highest accuracy by using big data [101]. These achievements
demonstrate the influence of modern technology on classical
disciplines.
(9) Model animals and experimental tools. Macaque
monkeys have been successfully cloned based on somatic cell
nuclear transfer [66], and non-human primate models of autism
have been created [68]. These model animals closest to human
beings will provide important support for medical research.
Chinese physicists, chemists, and information technology
experts have created a variety of scientific tools, making great
contributions to life sciences. Examples include the micro-imaging system that enables free-state brain imaging [102]
and single-protein spin resonance spectroscopy [103].
Due to space limitation, it is impossible to elaborate these
achievements and introduce more pioneering academic
achievements here. Please refer to the annual Top 10 Advances in Life Science in China. Each of them is a scientific
pearl and some of them have great potential for application.

______________________________________

⑤ Planting Rice Plants for the Motherland—Li Jiayang’s team won the first prize of the National Natural Science Award. Chinese Journal of Science,
2018-01-10(01).
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4 Trends of and recommendations for future
development of life science research in China
4.1

Development trends

China’s life science research has achieved remarkable
progress in the past 10 years and rewritten the global landscape of life sciences. The fight against COVID-19 by science and technology is a microcosm, in which Chinese
scientists have undergone severe tests, demonstrating good
performance from basic research to clinical performance. The
number of top 1% papers published by Chinese scientists was
only secondary to that of the United States, and most of the
top 20 papers with thousands of citations per paper came
from China. China was the first to identify the pathogen and
sequence the genome, identify ACE2 as the receptor of
SARS-CoV-2, and provide clinical treatment protocols and
experience, providing significant basic sharing for
COVID-19 prevention and control worldwide.
The future development of life sciences in China has three
advantages. ① Improved research capacity. This advantage
has been proved by the data in Figures 2 and 3. China has
excellent research achievements in almost all fields of life
sciences and will continue to expand its impact. ② Growing
research teams. A considerable number of teams are active in
various fields, forming a pyramid talent structure, and there
are still young talent dividends. More than 100 student teams
from China participate in the International Genetically Engineered Machine (iGEM) competition sponsored by the
Massachusetts Institute of Technology every year. One after
another, China has maintained a record of 30%–40% gold
medals, demonstrating the excellent youth reserve in life
sciences and the interdisciplinary fields. ③ Government
support. A series of key programs and special projects have
been established, involving the brain program, stem cell and
organ repair, synthetic biology, macromolecular machines,
microbiome, frontier biotechnology, IT (Information technology)-BT (biotechnology), medical devices, traditional
Chinese medicine, chronic disease prevention and treatment,
and reproductive health, with clear strategic development
goals. The National Natural Science Foundation of China
encourages exploration and original research, and the Chinese Academy of Sciences launches the Strategic Priority
Research Program, which together support life science research in China.

4.2 Problems and suggestions
Despite the remarkable progress in life science research in
China, there are urgent problems and new challenges to be
solved. Here are some thoughts and suggestions.
(1) Rationalizing the functional positioning and resource
allocation of various R&D sectors. After more than 40 years

of development and reform, the life science research forces in
China have formed several major sectors. As there is no clear
division between sectors or in resource allocation, homogeneity and disordered competition occur when everyone is
struggling to move forward. For example, a national institution for basic research in life sciences needs to obtain more
than 70% of its annual funding through competition with
other sectors. This is different from the international practice,
and it is difficult to form an “iron business” or “century-old
shop” (i.e., an internationally renowned research institution),
which increases the management cost of the entire research
system. This situation should be changed in the new round of
reform.
(2) Coordinating progressive and transformative research.
For historical reasons, the current life science knowledge
system in textbooks is mainly from the contributions of European and American scientists. Over the past decades, China’s scientific research has gradually bid farewell to the
tracking model and began to stand at the forefront of science
development. It is expected that Chinese researchers will
make more original achievements of “0-to-1”. I once talked
with Alan Finkel, the former chief scientific adviser to the
Australian government, about progressive and transformative
research. The consensus is that the transition from quantitative change to qualitative change is real. For example, Chinese virologists were able to take on the role at the outbreak
of COVID-19 because of the long period of endeavor in
tracing the origin of the SARS virus. It is equally important to
maintain broad support for exploratory research while challenging important scientific propositions and applied goals.
The innovation of “0-to-1” often refreshes our knowledge
system, which shows that disruptive innovation comes from
the fertile soil of innovation and the ocean of science, and is
difficult to predict and design.
(3) Accelerating the solving of the difficult problems of
biotechnology transformation. Biotechnology has made a
significant contribution to human health and food security.
The contribution rate of agricultural scientific and techno⑥
logical progress in China has exceeded 60% which, however, still has a long way to go compared with the modern
agriculture of developed economies. The gap between medical technology and biomedical engineering is even more
obvious, which is not repeated here. There are three reasons
for the gaps. ① Competitive technology stems from original
innovation, which requires persistent research and accumulation that is not eager for quick results and instant benefits.
② Paper-oriented evaluation still exists widely and many
research activities are carried out merely for paper’s sake.
However, when the quota of papers is achieved, researchers
involved in transformation are often marginalized, which
results in the shortage of research achievement supply. ③
The production-education-research mechanism has not been

______________________________________

⑥ Report of the China Agricultural and Rural Science and Technology Development during the 13th Five-Year Period released (2022-11-19).
http://www.gov.cn/xinwen/2021-11/22/content_5652387.htm.
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substantially established in many areas, and the gap between
laboratory and industry is difficult to overcome. Many successful experiences in science and technology development
parks are worth of popularizing. For example, the UpstairsDownstairs Innovation and Entrepreneurship Complex
jointly created by the Guangming District government of
Shenzhen and the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences is a good model that
compresses the spatial distance between research blocks and
⑦
start-ups to zero .
(4) Creating a healthy research culture and atmosphere. I
has ever co-chaired with the British researcher in a China-UK
Joint Seminar on Promoting Public Understanding of New
Biotechnology supported by the National Natural Science
⑧
Foundation of China and the Newton Found . We have
analyzed and discussed the mode of public participation and
communication with the emerging research topics, life science research paradigm, scientific research management,
mutual trust and mutual assistance, knowledge sharing, science ethics and law, etc. The enthusiasm and wisdom, forward-looking ideas, and willingness to share and inspire each
other among the participants remind me of many university
mottoes, college mottoes and their cultivation of students’
spirit. A healthy research culture and atmosphere may breed
advanced scientific thoughts. In contrast, contention for titles
and worldly application of projects have troubled front-line
researchers, eroding the scientific spirit and requiring a radical cure.
(5) Insisting on open research and international cooperation. Life sciences are the link of the community with a
shared future for mankind and have a long tradition of international cooperation. However, profound changes have
taken place in the world political and economic landscapes in
recent years, which are trampling the tradition of international cooperation. A study of InCtie/Web of Science
demonstrates that the number of research papers jointly published by Chinese and American researchers has been growing for decades and each other has become the largest
cooperative partner. In 2019, the number of research papers
jointly published by researchers in China and the United
States reached 66 600, which was the highest in history.
However, it declined for the first time in 2020 by 1.5%, followed by a further decline of 5.9% (9% in life sciences) in
2021, and a precipitous decline is likely to occur in 2022.
Under such circumstance, China can carry out life science
research with the aid of the mechanisms of the United Nations and intergovernmental organizations, such as the World
Health Organization (WHO) and the International Food and
Agriculture Organization (FAO), as well as the platforms of
various life science societies and multimedia, to persist in

cooperative research. The world will eventually return to
rationality.

5

Concluding remarks

China’s life science research has entered a high-quality
development stage. While continuing to expand the advantages, we should solve existing problems and make new
achievements to build a healthy and safe China, build up the
strength in science and technology, and contribute to
mankind.
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